Lytix Biopharma

About:

Lytix Biopharma is a pharmaceutical company specializing in anti-microbials and cancer therapeutics.

Website: http://www.lytixbiopharma.com

Top Investors: Sparebanken Nord-Norge, Norinnova Invest, Picasso Kapital, Norinnova Forvaltning, SkatteFUNN

Description:

Lytix Biopharma AS is a privately-owned pharmaceutical company focussed on anti-microbials and cancer therapeutics.

Total Funding Amount:

$11.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tromsø, Troms, Norway

Founded Date:

2003-01-01

Contact Email:

post(AT)lytixbiopharma.com

Founders:

Oystein Rekdal

Number of Employees:

11-50

Last Funding Date:

2023-10-16

IPO Status:

Private

Industries: